Lundbeck acquiert Longboard Pharmaceuticals pour 2,6 milliards de dollars pour renforcer le pipeline des neurosciences. Lundbeck acquires Longboard Pharmaceuticals for $2.6B to strengthen neuroscience pipeline.

Lundbeck a annoncé son acquisition de Longboard Pharmaceuticals pour environ 2,6 milliards de dollars. Lundbeck has announced its acquisition of Longboard Pharmaceuticals for about $2.6 billion. Cette initiative stratégique vise à renforcer considérablement le pipeline de neurosciences de Lundbeck, en améliorant sa position dans l'industrie pharmaceutique. This strategic move aims to significantly strengthen Lundbeck's neuroscience pipeline, enhancing its position in the pharmaceutical industry.